KPF
IQMDW

K2 Principal Fund’s Intelligent Medicine Acquisition Corp. Warrant IQMDW Stock Holding History

K2 Principal Fund’s Portfolio IQMDW Stock Details IQMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-98,684
Closed -$13K – 380
2022
Q2 		$13K Hold
98,684
– – ﹤0.01% 338
2022
Q1 		$27K Sell
98,684
-1,316
-1% -$480 ﹤0.01% 285
2021
Q4 		$49K Buy
+100,000
New +$50.2K ﹤0.01% 355

Other funds holding IQMDW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

K2 Principal Fund's IQMDW Position: Q3 2022 in Review

K2 Principal Fund sold out of Intelligent Medicine Acquisition Corp. Warrant (IQMDW) in Q3 2022, closing a stake of 98,684 shares — an estimated $13K sold.

K2 Principal Fund first reported a position in IQMDW in Q4 2021 and held it in 3 quarters. The position peaked at $49K in Q4 2021. 44 funds tracked by Wall St. Rank hold IQMDW as of Q3 2022.

  • K2 Principal Fund reported no remaining Intelligent Medicine Acquisition Corp. Warrant position as of Q3 2022 after selling out during the quarter.
  • K2 Principal Fund sold 98,684 Intelligent Medicine Acquisition Corp. Warrant shares in Q3 2022, an estimated $13K.
  • K2 Principal Fund first reported a position in Intelligent Medicine Acquisition Corp. Warrant in Q4 2021 and held it in 3 quarters.
  • K2 Principal Fund's Intelligent Medicine Acquisition Corp. Warrant position peaked at $49K in Q4 2021.
  • 44 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Warrant as of Q3 2022.

Based on K2 Principal Fund's 13F filing for Q3 2022, filed 14 Nov 2022.